Technavio has been monitoring the precision medicine software market and it is poised to grow by USD 882.65 mn during 2020-2024, progressing at a CAGR of about 11% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200921005394/en/
Technavio has announced its latest market research report titled Global Precision Medicine Software Market 2020-2024 (Graphic: Business Wire)
Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavios in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis. Download a Free Sample Report on COVID-19 Impacts
Frequently Asked Questions:
What are the major trends in the market? Digitization of healthcare is a major trend driving the growth of the market.
At what rate is the market projected to grow? The year-over-year growth for 2020 is estimated at 10.90% and the incremental growth of the market is anticipated to be $ 882.65 mn.
Who are the top players in the market? F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA, and Syapse Inc., are some of the major market participants.
What is the key market driver? The benefits of precision medicine is one of the major factors driving the market.
How big is the North America market? The North America region will contribute 45% of the market share.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. F. Hoffmann-La Roche Ltd., Fabric Genomics Inc., Gene42 Inc., Human Longevity Inc., International Business Machines Corp., Koninklijke Philips NV, NantHealth Inc., Roper Technologies Inc., SOPHiA GENETICS SA, and Syapse Inc. are some of the major market participants. The benefits of precision medicine will offer immense growth opportunities. To make most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Story continues
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
View market snapshot before purchasing
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Precision Medicine Software Market 2020-2024: Segmentation
Precision Medicine Software Market is segmented as below:
Delivery Mode
Geographic Landscape
Asia
Europe
North America
ROW
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40844
Precision Medicine Software Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The precision medicine software market report covers the following areas:
Precision Medicine Software Market Size
Precision Medicine Software Market Trends
Precision Medicine Software Market Industry Analysis
This study identifies the digitization of healthcare as one of the prime reasons driving the Precision Medicine Software Market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavios in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports. Technavio's SUBSCRIPTION platform
Precision Medicine Software Market 2020-2024: Key Highlights
CAGR of the market during the forecast period 2020-2024
Detailed information on factors that will assist precision medicine software market growth during the next five years
Estimation of the precision medicine software market size and its contribution to the parent market
Predictions on upcoming trends and changes in consumer behavior
The growth of the precision medicine software market
Analysis of the markets competitive landscape and detailed information on vendors
Comprehensive details of factors that will challenge the growth of precision medicine software market vendors
Table of Contents:
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY DELIVERY MODE
Market segmentation by delivery mode
Comparison by delivery mode
On-premise - Market size and forecast 2019-2024
Cloud-based - Market size and forecast 2019-2024
Market opportunity by delivery mode
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2019-2024
Europe - Market size and forecast 2019-2024
Asia - Market size and forecast 2019-2024
ROW - Market size and forecast 2019-2024
Key leading countries
Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 11: MARKET TRENDS
Rise in clinical trials in developing nations
Digitization of healthcare
Improvement in healthcare and IT infrastructure in emerging economies
PART 12: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 13: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
F. Hoffmann-La Roche Ltd.
Fabric Genomics, Inc.
Gene42 Inc.
Human Longevity, Inc.
International Business Machines Corp.
Koninklijke Philips NV
NantHealth Inc.
Roper Technologies Inc.
SOPHiA GENETICS SA
Syapse Inc.
PART 14: APPENDIX
PART 15: EXPLORE TECHNAVIO
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200921005394/en/
Contacts
Technavio ResearchJesse MaidaMedia & Marketing ExecutiveUS: +1 844 364 1100UK: +44 203 893 3200Email: media@technavio.com Website: http://www.technavio.com/
View original post here:
Precision Medicine Software Market- Roadmap for Recovery from COVID-19|Benefits Of Precision Medicine to Boost the Market Growth | Technavio - Yahoo...